Search results
Scenic Biotech Enters into Research Collaboration with Bristol Myers Squibb - Bristol-Myers Squibb...
Benzinga· 3 hours agoScenic Biotech, a pioneer in the field of modifier therapies for severe genetic disorders, today announced that it has entered into a research collaboration with Bristol Myers Squibb BMY to ...
Why Bristol Myers Squibb Stock Is Sinking Today
Motley Fool via Yahoo Finance· 5 days agoShares of Bristol Myers Squibb (NYSE: BMY) were down 8.3% as of 11:19 a.m. ET on Thursday. The sell-off came after the big drugmaker announced its...
Repertoire® Immune Medicines and Bristol Myers Squibb Announce Multi-Year Strategic Collaboration to...
Morningstar· 1 day agoRepertoire® Immune Medicines, a biotechnology company pioneering the discovery and development of programmable T cell targeted immune medicines, announced today that it has entered a multi-year ...
Judge rejects J&J, Bristol Myers Squibb challenges to Medicare drug-price negotiations
CNBC· 14 hours agoA federal judge in New Jersey on Monday rejected Johnson & Johnson's and Bristol Myers Squibb's...
Bristol-Myers Squibb Expected to Earn Q2 2024 Earnings of $1.76 Per Share (NYSE:BMY)
ETF DAILY NEWS· 1 day agoBristol-Myers Squibb (NYSE:BMY – Free Report) – Equities research analysts at Leerink Partnrs lowered their Q2 2024 EPS estimates for shares of Bristol-Myers Squibb in a report issued on Thursday ...
Bristol-Myers Squibb stock target cut on cost cutting measures By Investing.com
Investing.com· 19 hours agoOn Monday, Deutsche Bank (ETR:DBKGn) adjusted its outlook on Bristol-Myers Squibb Co. shares...
Bristol Myers Squibb enlists Cellares amid industry manufacturing “land grab”
BioPharma-Reporter· 22 hours agoCellares has received a vote of confidence in its integrated and automated cell therapy factories as...
Analyzing Bristol-Myers Squibb Co.
Knox Daily· 21 hours agoBristol-Myers Squibb Co.’s filing revealed that its Chief Executive Officer BOERNER CHRISTOPHER S. acquired Company’s shares for reported $99560.0 on Dec 05 ’23. In the deal valued at $49.78 ...
Is Bristol Myers Squibb Stock a Millionaire Maker?
Motley Fool via Yahoo Finance· 5 days agoMany top healthcare stocks provide investors with long-term stability, promising growth prospects, and in some cases even a dividend. Yet, investors...
Bristol-Myers Squibb Layoffs 2024: What to Know About the Latest BMY Job Cuts
InvestorPlace· 5 days agoBristol-Myers Squibb (NYSE:BMY) layoffs are a hot topic on Thursday after the biopharmaceutical...